Clinical Trial: A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer

A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer


Sponsor and Collaborators
Herlev Hospital
Odense University Hospital

Contact
Jørn Herrstedt, professor
+45 6541 3634
herrstedt@ouh.regionsyddanmark.dk

Hanne Havsteen, consultant
+45 4488 2527
hahav@heh.regionh.dk

Principal Investigator
Jørn Herrstedt, professor
Odense University Hospital

Clinical Trials.gov Identifier
NCT00772798
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs